Phathom Pharmaceuticals (PHAT) Selling, General & Administrative (2018 - 2026)
Phathom Pharmaceuticals (PHAT) posted Selling, General & Administrative of $55.33 million for Q2 2026, down 35.1% from $85.31 million a year earlier but up 2.4% from the prior quarter.
Powered by 
Analysis
Phathom Pharmaceuticals (PHAT) Selling, General & Administrative (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Phathom Pharmaceuticals was $209.27 million, down 37.1% year-over-year; for FY2025, it was $279.72 million, down 3.8% from FY2024.
- Annual Selling, General & Administrative shows a five-year compound annual growth rate of 59.0% (FY2020 to FY2025).
- In prior years, Phathom Pharmaceuticals' Selling, General & Administrative was $290.66 million in FY2024 (+146.5%), $117.93 million in FY2023 (+16.8%), $101 million in FY2022 (+61.0%) and $62.74 million in FY2021 (+128.0%).
- Quarterly Selling, General & Administrative has run from a low of $16.53 million in Q3 2021 to a high of $94.47 million in Q1 2025 over five years.
- On a year-over-year basis, Selling, General & Administrative has declined in each of the last four quarters, with growth averaging 22.2% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q2 2024, with growth of 300.7%; the weakest was Q1 2026, with a decline of 42.8%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $54.01 million (Q1 2026), $48.37 million (Q4 2025) and $51.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Phathom Pharmaceuticals | 566.90 Mn | -73.06 Mn | 59.18 Mn | 55.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.33 Mn |
| Mar 31, 2026 | 54.01 Mn |
| Dec 31, 2025 | 48.37 Mn |
| Sep 30, 2025 | 51.56 Mn |
| Jun 30, 2025 | 85.31 Mn |
| Mar 31, 2025 | 94.47 Mn |
| Dec 31, 2024 | 76.68 Mn |
| Sep 30, 2024 | 76.10 Mn |
| Jun 30, 2024 | 75.87 Mn |
| Mar 31, 2024 | 62.01 Mn |
| Dec 31, 2023 | 57.00 Mn |
| Sep 30, 2023 | 23.40 Mn |
| Jun 30, 2023 | 18.94 Mn |
| Mar 31, 2023 | 18.60 Mn |
| Dec 31, 2022 | 30.70 Mn |
| Sep 30, 2022 | 23.51 Mn |
| Jun 30, 2022 | 26.55 Mn |
| Mar 31, 2022 | 20.25 Mn |
| Dec 31, 2021 | 19.49 Mn |
| Sep 30, 2021 | 16.53 Mn |
API Access
Phathom Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PHAT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "PHAT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PHAT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();